Skip to content

To Evaluate The Efficacy Of Individualized Homoeopathic Treatment In Patients Suffering From Rheumatoid Arthritis.

A Randomized Controlled Trial To Evaluate The Efficacy Of Individualized Homoeopathic Treatment In Patients Suffering From Rheumatoid Arthritis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098192
Enrollment
100
Registered
2025-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: To give Individualized homoeopathic medicines to patients suffering from Rheumatoid Arthritis: To give individualized homoeopathic medicines to patients suffering from Rheumatoid Arthri

Sponsors

TANTIA UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 25-60 years with clinically diagnosed and undiagnosed Rheumatoid Arthritis 2 . Gender both Male and Female 3. Both serological positive and negative cases

Exclusion criteria

Exclusion criteria: 1. Patients coming with severe comorbidities like CKD , LIVEER DISEASES , HEART DISEASES etc. 2 . Pregnant or Lactating individuals

Design outcomes

Primary

MeasureTime frame
Improvement in Rheumatoid Arthritis symptoms in patients treated with homoeopathic medicines compared to placeboTimepoint: Follow ups every 15 days for 6 months

Secondary

MeasureTime frame
Symptomatic amelioration in patients suffering from Rheumatoid Arthritis by counselling and lifestyle managementTimepoint: Follow ups every 15 days for six months

Countries

India

Contacts

Public ContactLAKSHAY MAHAJAN

Sri Ganganagar Homoeopathic Medical College Hospital and Research Institute

sgnhh@yahoo.com9414225433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026